152 related articles for article (PubMed ID: 30884196)
21. CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice.
Forsberg MH; Ciecko AE; Bednar KJ; Itoh A; Kachapati K; Ridgway WM; Chen YG
J Immunol; 2017 May; 198(10):3857-3868. PubMed ID: 28363905
[TBL] [Abstract][Full Text] [Related]
22. Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes.
Li L; Hui H; Jia X; Zhang J; Liu Y; Xu Q; Zhu D
Sci Rep; 2016 Dec; 6():37894. PubMed ID: 27905403
[TBL] [Abstract][Full Text] [Related]
23. Interaction of dendritic cells and T lymphocytes for the therapeutic effect of Dangguiliuhuang decoction to autoimmune diabetes.
Liu T; Cao H; Ji Y; Pei Y; Yu Z; Quan Y; Xiang M
Sci Rep; 2015 Sep; 5():13982. PubMed ID: 26358493
[TBL] [Abstract][Full Text] [Related]
24. A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.
Walz M; Overbergh L; Mathieu C; Kolb H; Martin S
Horm Metab Res; 2002 Oct; 34(10):561-9. PubMed ID: 12439784
[TBL] [Abstract][Full Text] [Related]
25. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
Serreze DV; Niens M; Kulik J; DiLorenzo TP
Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
[TBL] [Abstract][Full Text] [Related]
26. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
[TBL] [Abstract][Full Text] [Related]
27. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice.
Mor A; Kloog Y; Keren G; George J
Eur J Pharmacol; 2009 Aug; 616(1-3):301-5. PubMed ID: 19527709
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-35 administration counteracts established murine type 1 diabetes--possible involvement of regulatory T cells.
Singh K; Kadesjö E; Lindroos J; Hjort M; Lundberg M; Espes D; Carlsson PO; Sandler S; Thorvaldson L
Sci Rep; 2015 Jul; 5():12633. PubMed ID: 26224624
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice.
Kornete M; Beauchemin H; Polychronakos C; Piccirillo CA
Autoimmunity; 2013 Jun; 46(4):259-68. PubMed ID: 23256897
[TBL] [Abstract][Full Text] [Related]
30. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells.
Flores RR; Zhou L; Robbins PD
Gene Ther; 2014 Aug; 21(8):715-22. PubMed ID: 24849041
[TBL] [Abstract][Full Text] [Related]
31. Prolactin as an Adjunct for Type 1 Diabetes Immunotherapy.
Hyslop CM; Tsai S; Shrivastava V; Santamaria P; Huang C
Endocrinology; 2016 Jan; 157(1):150-65. PubMed ID: 26512750
[TBL] [Abstract][Full Text] [Related]
32. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
33. Rapamycin/GABA combination treatment ameliorates diabetes in NOD mice.
He S; Zhang Y; Wang D; Tao K; Zhang S; Wei L; Chen Q
Mol Immunol; 2016 May; 73():130-7. PubMed ID: 27082922
[TBL] [Abstract][Full Text] [Related]
34. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
Ly D; Mi QS; Hussain S; Delovitch TL
J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
[TBL] [Abstract][Full Text] [Related]
35. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
36. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation.
Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K
Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702
[TBL] [Abstract][Full Text] [Related]
37. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
[TBL] [Abstract][Full Text] [Related]
38. Exposure to DDT metabolite p,p'-DDE increases autoimmune type 1 diabetes incidence in NOD mouse model.
Cetkovic-Cvrlje M; Olson M; Schindler B; Gong HK
J Immunotoxicol; 2016; 13(1):108-18. PubMed ID: 25721050
[TBL] [Abstract][Full Text] [Related]
39. Macrophage migration inhibitory factor and development of type-1 diabetes in non-obese diabetic mice.
Bojunga J; Kusterer K; Bacher M; Kurek R; Usadel KH; Renneberg H
Cytokine; 2003 Feb; 21(4):179-86. PubMed ID: 12788306
[TBL] [Abstract][Full Text] [Related]
40. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
